Fucci Michael
Fucci Michael's purchase track record
Fucci Michael has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 2/19/2026 | CNDT | $87K | +11.9% | +7.7% | +11.4% |
| 11/17/2023 | FTK | $30K | -24.3% | -3.5% | +17.5% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Acadia Healthcare Sets Q3 2026 Earnings Date. Acadia Healthcare announced the date for its third-quarter 2026 earnings release. This update provides a timeline for the next major financial report from the company. The stock is currently trading within its 52-week range of $11.43 to $35.83, with an average analyst target price of $33.79.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
Conduent Sets Investor Day for September 30, 2026. Conduent announced it will host an Investor Day on September 30, 2026. This event is expected to provide updates on the company's strategy and performance. The stock is currently trading near its 52-week low, making this upcoming presentation a key moment for stakeholders to assess the company's outlook.
Transaction History
| FTK | ▲ Buy | Grant | 5,099 | $0 | 5/15/2026 | View on chart |
| ACHC | ▲ Buy | Grant | 6,331 | $0 | 5/6/2026 | View on chart |
| CNDT | ▲ Buy | Open Market | 60,000 | $87K | 2/19/2026 | View on chart |
| CNDT | ▲ Buy | Grant | 92,683 | $190K | 1/15/2026 | View on chart |
| CNDT | ▲ Buy | Grant | 13,419 | $32K | 10/31/2025 | View on chart |
| ACHC | ▲ Buy | Grant | 7,032 | $0 | 5/29/2025 | View on chart |
| FTK | ▲ Buy | Grant | 6,394 | $0 | 5/16/2025 | View on chart |
| FTK | ▲ Buy | Grant | 22,173 | $0 | 6/5/2024 | View on chart |
| ACHC | ▲ Buy | Grant | 2,414 | $0 | 5/23/2024 | View on chart |
| FTK | ▲ Buy | Open Market | 100 | $389 | 11/17/2023 | View on chart |
| FTK | ▲ Buy | Open Market | 7,593 | $30K | 11/17/2023 | View on chart |
| FTK | ▲ Buy | Grant | 136,986 | $0 | 7/1/2023 | View on chart |
| ACHC | ▲ Buy | Grant | 2,229 | $0 | 5/18/2023 | View on chart |
| FTK | ▲ Buy | Grant | 82,645 | $0 | 8/4/2022 | View on chart |
| ACHC | ▲ Buy | Grant | 2,303 | $0 | 5/19/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
Flotek Industries Announces Q3 2026 Earnings Release
Flotek Industries said it will release its third‑quarter 2026 earnings and hold a conference call on the same day. The company’s earnings announcement has prompted analysts to debate whether the stock is undervalued or above fair value, with a target range of $32 to $44. The stock is trading near its 52‑week low and shows a moderate RSI of 36.5, indicating room for movement.
Flotek Industries Announces Q3 2026 Earnings Release. Flotek Industries said it will release its third‑quarter 2026 earnings and hold a conference call on the same day. The company’s earnings announcement has prompted analysts to debate whether the stock is undervalued or above fair value, with a target range of $32 to $44. The stock is trading near its 52‑week low and shows a moderate RSI of 36.5, indicating room for movement.